# Exploring Drugs Targeting Hippo Pathway

> **NIH NIH R35** · FRED HUTCHINSON CANCER CENTER · 2024 · $78,390

## Abstract

Project Summary/Abstract
Per the NCI Diversity Supplement Guidelines, this section is not required. The research supplement
proposal does not change the activities of the Parent Award.

## Key facts

- **NIH application ID:** 11064181
- **Project number:** 3R35CA253119-05S2
- **Recipient organization:** FRED HUTCHINSON CANCER CENTER
- **Principal Investigator:** Eric C. Holland
- **Activity code:** R35 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $78,390
- **Award type:** 3
- **Project period:** 2021-09-21 → 2028-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11064181

## Citation

> US National Institutes of Health, RePORTER application 11064181, Exploring Drugs Targeting Hippo Pathway (3R35CA253119-05S2). Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/grant/nih/11064181. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
